Skip to content

Author

Long-Long Yan

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Empagliflozin Improves Atherosclerosis by Promoting Mitophagy in Endothelial Cells.

EMPA inhibits the progression of AS by activating Pink1/Parkin-mediated mitophagy, thereby improving mitochondrial function and alleviating endothelial injury and providing a novel basis for the cardiovascular protective mechanisms of EMPA.

Long-Long Yan, Jing-Jing Lu, Wen-Dong Xu et al. · 0 citations
Sep 2026

Dapagliflozin Ameliorates Pulmonary Arterial Hypertension-Induced Right Heart Failure via Ketone Body Metabolism and Mitochondrial Function Enhancement.

BACKGROUND Pulmonary arterial hypertension (PAH)-induced right ventricular (RV) failure increases reliance on ketones. The efficacy of SGLT2 inhibitors, known to modulate ketone metabolism, in this context remains unclear. METHODS A PAH model was established in Sprague-Dawley rats via a single intraperitoneal injecti...

Wen-Dong Xu, Jia Liu, Long-Long Yan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.